C85 Other specified and unspecified types of non-Hodgkin lymphoma

Name of the Condition

• Other specified and unspecified types of non-Hodgkin lymphoma
• C85

Summary

Non-Hodgkin lymphoma (NHL) is a group of blood cancers that affect the lymphatic system. This code encompasses NHL types that are not classified into more specific subcategories or where the subtype is not clearly defined. The lymphatic system, part of the immune system, is involved in fighting infections, and NHL arises from abnormal lymphocyte growth.

Causes

The exact cause of non-Hodgkin lymphoma is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections (e.g., Epstein-Barr virus), immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Swollen lymph nodes (neck, armpits, groin)
• Fever, night sweats, or unexplained weight loss
• Fatigue or weakness
• Abdominal pain or swelling
• Persistent cough or chest discomfort
• Itching or skin rashes

Diagnosis

Diagnosis typically includes a physical exam to check for enlarged lymph nodes, blood tests to assess cell counts and organ function, imaging (e.g., CT, PET scans) to locate tumors, and a biopsy of lymphatic tissue to confirm malignancy. Additional tests may evaluate disease spread or specific subtypes.

Treatment Options

Treatment depends on the NHL subtype, stage, and patient health. Options may include chemotherapy, radiation therapy, immunotherapy, targeted therapy, or stem cell transplantation. Clinical trials or combination therapies are sometimes used for advanced or refractory cases.

Prognosis and Follow-Up

Prognosis varies widely based on subtype, stage, and response to treatment. Regular follow-up with imaging, blood tests, and physical exams is essential to monitor for recurrence or progression. Long-term survivors may require ongoing care for late effects of treatment.

Complications

Potential complications include infection due to weakened immunity, organ damage from tumor growth, treatment-related side effects (e.g., fatigue, neuropathy), or transformation to a more aggressive lymphoma. Rarely, NHL may spread to the central nervous system or other organs.

Lifestyle & Prevention

While prevention is not always possible, maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (e.g., smoking, excessive alcohol) may reduce risk. Vaccinations (e.g., for hepatitis B) and managing immune conditions can also help.

When to Seek Professional Help

Seek care if you experience persistent swollen lymph nodes, unexplained weight loss, fever, or fatigue lasting more than two weeks. Early evaluation is critical for timely diagnosis and treatment planning.

Tips for Medical Coders

Use C85 for "Other specified and unspecified types of non-Hodgkin lymphoma" when documentation does not specify a more detailed subtype or site. Ensure the code aligns with clinical notes, as specificity may impact reporting. Verify that no more precise code (e.g., for a named NHL subtype) is applicable before using C85.